The company said it put to a vote at its May 7, 2025 annual meeting the election of Stuart M. Essig, Jonathan Jay Mazelsky and M. Anne Szostak as Class III directors, for terms expiring at the 2028 annual meeting. Mazelsky received 67,067,059 votes for and 817,668 against.

1. 01

   The company said it put to a vote at its May 7, 2025 annual meeting the election of Stuart M. Essig, Jonathan Jay Mazelsky and M. Anne Szostak as Class III directors, for terms expiring at the 2028 annual meeting. Mazelsky received 67,067,059 votes for and 817,668 against.

2. 02

   IDEXX Laboratories said shareholders approved, on the board's recommendation, an amendment removing all supermajority voting requirements from the certificate of incorporation, with 67,764,787 votes for and 96,937 against.

3. 03

   The company said shareholders approved an amendment reflecting Delaware law provisions that allow officer exculpation in the certificate of incorporation, with 60,474,938 votes for and 7,367,839 against.

4. 04

   The company said it filed a Certificate of Elimination with the Delaware Secretary of State on May 7, 2025, removing the authority to issue Series A Junior Participating Preferred Stock. The board approved amending and restating the by-laws on the same day, effective immediately.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.